메뉴 건너뛰기




Volumn 15, Issue 1, 2009, Pages 73-77

The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism

Author keywords

Factor V Leiden; Genetics; Plasminogen activator inhibitor 1; Prothrombin 20210; Pulmonary thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

EID: 58449097602     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607305110     Document Type: Article
Times cited : (16)

References (20)
  • 1
    • 0036881059 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 levels and polymorphisms. Association with venous thromboembolism
    • Francis CW Plasminogen activator inhibitor-1 levels and polymorphisms. Association with venous thromboembolism. Arch Pathol Lab Med. 2002 ; 126: 1401-1404.
    • (2002) Arch Pathol Lab Med. , vol.126 , pp. 1401-1404
    • Francis, C.W.1
  • 2
    • 0035169759 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor type-1: Basic mechanisms, regulation, and role for thromboembolic disease
    • Huber K. Plasminogen activator inhibitor type-1: basic mechanisms, regulation, and role for thromboembolic disease. J Thromb Thrombolysis. 2001 ; 11: 183-193.
    • (2001) J Thromb Thrombolysis , vol.11 , pp. 183-193
    • Huber, K.1
  • 3
    • 0031732774 scopus 로고    scopus 로고
    • 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep-vein thrombosis
    • Sartori MT, Wiman B., Vettore S., et al. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep-vein thrombosis. Thromb Haemost. 1998 ; 80: 956-960.
    • (1998) Thromb Haemost , vol.80 , pp. 956-960
    • Sartori, M.T.1    Wiman, B.2    Vettore, S.3
  • 4
    • 0021889294 scopus 로고
    • Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: Low concentration of plasminogen activator increased concentration of plasminogen activator inhibitor
    • Nilsson IM, Ljungner H., Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator increased concentration of plasminogen activator inhibitor. BMJ. 1985 ; 290: 1453-1456.
    • (1985) BMJ , vol.290 , pp. 1453-1456
    • Nilsson, I.M.1    Ljungner, H.2    Tengborn, L.3
  • 5
    • 0029880730 scopus 로고    scopus 로고
    • The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism
    • the Duration of Anticoagulation (DURAC) Trial Study Group.
    • Schulman S., Wiman B., the Duration of Anticoagulation (DURAC) Trial Study Group. The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Thromb Haemost. 1996 ; 75: 607-611.
    • (1996) Thromb Haemost , vol.75 , pp. 607-611
    • Schulman, S.1    Wiman, B.2
  • 6
    • 0031016432 scopus 로고    scopus 로고
    • Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men
    • Ridker PM, Hennekens CH, Lindpaintner K., et al. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation. 1997 ; 95: 59-63.
    • (1997) Circulation , vol.95 , pp. 59-63
    • Ridker, P.M.1    Hennekens, C.H.2    Lindpaintner, K.3
  • 7
    • 0031966645 scopus 로고    scopus 로고
    • The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: Relationship to plasma PAI-1 level in venous thromboembolism
    • Stegnar M., Uhrin P., Petrnel P., et al. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost. 1998 ; 9: 975-979.
    • (1998) Thromb Haemost , vol.9 , pp. 975-979
    • Stegnar, M.1    Uhrin, P.2    Petrnel, P.3
  • 8
    • 0034209632 scopus 로고    scopus 로고
    • The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism
    • Hooper WC, Lally C., Austin H., et al. The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res. 2000 ; 99: 223-230.
    • (2000) Thromb Res , vol.99 , pp. 223-230
    • Hooper, W.C.1    Lally, C.2    Austin, H.3
  • 9
    • 0242333862 scopus 로고    scopus 로고
    • Factor V leiden, prothrombin 20210G-A, methylene tetrahydrofolate reductase 677C-T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism
    • Meglic L., Stegnar M., Milanez T., et al. Factor V leiden, prothrombin 20210G-A, methylene tetrahydrofolate reductase 677C-T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism. Eur J Obstet Gynecol Reprod Biol. 2003 ; 111: 157-163.
    • (2003) Eur J Obstet Gynecol Reprod Biol , vol.111 , pp. 157-163
    • Meglic, L.1    Stegnar, M.2    Milanez, T.3
  • 10
    • 0033967394 scopus 로고    scopus 로고
    • Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV 1691 G-A
    • Akar N., Yilmaz E., Akar E., et al. Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV 1691 G-A. Thromb Res. 2000 ; 97: 227-230.
    • (2000) Thromb Res , vol.97 , pp. 227-230
    • Akar, N.1    Yilmaz, E.2    Akar, E.3
  • 11
    • 0033621632 scopus 로고    scopus 로고
    • Effect of MTHFR 677 C-T, 1298 A-C and 1317 T-C on Factor V 1691 mutation in Turkish DVT patients
    • Akar N., Akar E., Akcay R., et al. Effect of MTHFR 677 C-T, 1298 A-C and 1317 T-C on Factor V 1691 mutation in Turkish DVT patients. Thromb Res. 2000 ; 97: 163-167.
    • (2000) Thromb Res , vol.97 , pp. 163-167
    • Akar, N.1    Akar, E.2    Akcay, R.3
  • 12
    • 17744410104 scopus 로고    scopus 로고
    • Prothrombin gene 20210 G-A mutation in the Turkish population
    • Akar N., Misirlioglu M., Akar E., et al. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol. 1998 ; 58: 249.
    • (1998) Am J Hematol , vol.58 , pp. 249
    • Akar, N.1    Misirlioglu, M.2    Akar, E.3
  • 13
    • 0346903208 scopus 로고    scopus 로고
    • Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis
    • Barcellona D., Lara F., Cauli C., et al. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thromb Haemost. 2003 ; 90: 1061-1064.
    • (2003) Thromb Haemost , vol.90 , pp. 1061-1064
    • Barcellona, D.1    Lara, F.2    Cauli, C.3
  • 14
    • 0033871724 scopus 로고    scopus 로고
    • Influence of the -675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V leiden
    • Visanji JM, Seargent J., Tahri D., et al. Influence of the -675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V leiden. Br J Haematol. 2000 ; 110: 135-138.
    • (2000) Br J Haematol , vol.110 , pp. 135-138
    • Visanji, J.M.1    Seargent, J.2    Tahri, D.3
  • 15
    • 0031725369 scopus 로고    scopus 로고
    • Plasminogen activator inhibitor-1 4G/4G genotype is associated with cerebral sinus thrombosis in factor V leiden carriers
    • Junker R., Nabavi DG, Wolff E., et al. Plasminogen activator inhibitor-1 4G/4G genotype is associated with cerebral sinus thrombosis in factor V leiden carriers. Thromb Haemost. 1998 ; 80: 706-707.
    • (1998) Thromb Haemost , vol.80 , pp. 706-707
    • Junker, R.1    Nabavi, D.G.2    Wolff, E.3
  • 16
    • 2642692693 scopus 로고    scopus 로고
    • A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency
    • Zöller B., Frutos PB, Dahlback B. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Thromb Haemost. 1998 ; 79: 802-807.
    • (1998) Thromb Haemost , vol.79 , pp. 802-807
    • Zöller, B.1    Frutos, P.B.2    Dahlback, B.3
  • 17
    • 0033785047 scopus 로고    scopus 로고
    • The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome
    • Tassies D., Espinosa G., Munoz-Rodriguez FJ, et al. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis Rheum. 2000 ; 43: 2349-2358.
    • (2000) Arthritis Rheum , vol.43 , pp. 2349-2358
    • Tassies, D.1    Espinosa, G.2    Munoz-Rodriguez, F.J.3
  • 19
    • 0033739241 scopus 로고    scopus 로고
    • Deep vein thrombosis and pulmonary embolism: A single entity with different risk factors
    • Perrier A. Deep vein thrombosis and pulmonary embolism: a single entity with different risk factors. Chest. 2000 ; 118: 1234-1236.
    • (2000) Chest , vol.118 , pp. 1234-1236
    • Perrier, A.1
  • 20
    • 33847733692 scopus 로고    scopus 로고
    • Management of pulmonary thromboembolic diseases
    • Crapo JD, Glassroth J, Karlinsky J, King TE Jr, eds. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins;
    • Morris TA Management of pulmonary thromboembolic diseases. In: Crapo JD, Glassroth J, Karlinsky J, King TE Jr, eds. Baum's Textbook of Pulmonary Diseases. 7 th ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2004: 747-771.
    • (2004) Baum's Textbook of Pulmonary Diseases , pp. 747-771
    • Morris, T.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.